Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127337911 | 12733791 | 1 | I | 20110228 | 20110607 | 20160912 | 20160912 | EXP | US-ROCHE-782590 | ROCHE | 82.83 | YR | M | Y | 91.20000 | KG | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127337911 | 12733791 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAY 1. CYCLE: 21 DAYS. LAST DRUG OF THE DRUG: 28 FEBRUARY 2011.?DOSE: 1380 MG | U | 125085 | 15 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 127337911 | 12733791 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | OVER 60 MINUTES ON DAY 1. CYCLE: 21 DAYS.?DOSE: 155 MG TO 169 MG | U | 0 | 75 | MG/M**2 | |||||||
| 127337911 | 12733791 | 3 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | ON DAYS 1-14. CYCLE: 21 DAYS. LAST DOSE OF THE DRUG: 3 MARCH 2011.?DOSE: 140 MG TO 350 MG | U | 0 | |||||||||
| 127337911 | 12733791 | 4 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | DOSE REDUCED. | U | 0 | |||||||||
| 127337911 | 12733791 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | CYCLE: 21 DAYS?DOSE: 105 MG TO 1930 MG. | U | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127337911 | 12733791 | 1 | Prostate cancer metastatic |
| 127337911 | 12733791 | 2 | Prostate cancer metastatic |
| 127337911 | 12733791 | 3 | Prostate cancer metastatic |
| 127337911 | 12733791 | 5 | Prostate cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127337911 | 12733791 | HO |
| 127337911 | 12733791 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127337911 | 12733791 | Anaemia | |
| 127337911 | 12733791 | Confusional state | |
| 127337911 | 12733791 | Delirium | |
| 127337911 | 12733791 | Platelet count decreased | |
| 127337911 | 12733791 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127337911 | 12733791 | 2 | 20101025 | 0 | ||
| 127337911 | 12733791 | 5 | 20101025 | 0 |